Submitted by Anonymous (not verified) on 22 October 2024 - 14:31
Orphan designation: 2-Hydroxypropyl-β-cyclodextrin Treatment of Niemann-Pick's disease, type C, 26/04/2013 Positive
Source:
Orphan designation: 2-Hydroxypropyl-β-cyclodextrin Treatment of Niemann-Pick's disease, type C, 26/04/2013 Positive